C(O)(C(F)(F)F)=O.[Cl:8][C:9]1[CH:10]=[C:11]([CH:15]([O:29][CH2:30][C:31]([NH:33][CH2:34][CH3:35])=[O:32])[C@@H:16]2[CH2:21][CH2:20][CH2:19][N:18](C(OC(C)(C)C)=O)[CH2:17]2)[CH:12]=[CH:13][CH:14]=1>C(Cl)Cl>[Cl:8][C:9]1[CH:10]=[C:11]([CH:15]([C@@H:16]2[CH2:21][CH2:20][CH2:19][NH:18][CH2:17]2)[O:29][CH2:30][C:31]([NH:33][CH2:34][CH3:35])=[O:32])[CH:12]=[CH:13][CH:14]=1To a stirred solution of TFA in CH2Cl2 (20% v/v, 5 mL) was added (3R)-tert-butyl 3-((3-chlorophenyl)(2-(ethylamino)-2-oxoethoxy)methyl)piperidine-1-carboxylate (57.9 mg, 0.0141 mmol). The reaction was monitored by tlc (elution solvent: 5:1 petroleum ether/EtOAc). When the reaction was complete, the mixture was washed with satd aq NaHCO3 and water, dried over Na2SO4 and concentrated to give 2-((3-chlorophenyl)((R)-piperidin-3-yl)methoxy)-N-ethylacetamide (40 mg, 91%). MS (E/Z): 311 (M+H+).
読み込み中…